Localisation, Trump & Covid-19: the best things to ever happen to China

Kay Van-Petersen
Global Macro Strategist

Summary:  Adversity will take China's 2025-2035 plans, which are all about technology, moving up the value chain and developing tech infrastructure, and bring them forward

The current focus going into Q3 is the staggering disconnect between the damage that we have seen globally from Covid-19 – economically, socially, politically and from a humanitarian perspective – and the market response. 

While the economic contractions, close-to-standstill activity and job losses across so many metrics have seen multi-decade records broken (i.e. unemployment or economic growth), listed asset classes have only soared higher. Some indices, such as the NASDAQ, have hit all-time highs.  

As an experienced volatility trader (codename Vega) made clear on a recent macro group call: “make no mistake, this is the worst economic time of your life”, so perhaps we shouldn’t use the level of the equity market as a barometer for the system’s underlying health, fractures and potential breaks. It’s worth noting that this was someone who made +50% in Q1 – they are very cognisant of the disconnect between asset prices and the underlying fundamentals in the economy.  

There will be some natural low-hanging fruit and pent-up demand as the world reopens fully, but there will also be risks: from second-wave infections, further lockdowns and more. As cited often on the Macro Dragon, my take is that the probability of another co-ordinated global shutdown is almost 0% – the costs economically, politically and from a stability standpoint are just too high for almost all countries.  

What we can say with high probability is that the monetary and fiscal policies of the world will keep the accelerator pushed down on loose and accommodative policies for a long time. Liquidity is currently the primary driver in regards to the ascent of listed asset prices, with fundamentals gagged and bound in the boot of the car. At some point this will reverse, but it could be 6-18 months or even years away. After Abenomics, the Nikkei went up circa +150% over 3 years.  

The key global backdrop on all this however – predominantly brought to light by the Trump administration, but now globally in vogue and almost certain to continue even in a Biden presidency –  is localisation, the inverse of globalisation.  
China is facing the perfect storm of adversity and challenges, including the costs of Covid-19, US-China relations deteriorating, the west backing Hong Kong over Beijing and, still to come, a global backlash that is only set to increase once the Covid dust settles on who is to blame for all this (think Occupy Wall Street x 1,000).  

Adversity, though, will only make a country more resilient and innovative, forcing it to tap into its true potential. Trump and Covid-19 are going to be the best things that have happened to China – a function of which will spill net positive to the rest of the world – in that it will accelerate Beijing’s plans to go from being export dependent to domestic-consumer driven. It will take China’s 2025-2035 plans, which are all about technology, moving up the value chain and developing tech infrastructure, and bring them forward. Finally, it will open China’s markets and accelerate reform which has been held back by export dependency.  

Overall, localisation will raise global competition. Globalisation lowers global competition: why innovate, when you can just find a lower-cost producer?  

The likely net result of a more localised and domestic-consumer-driven China is:  

  • Breakthroughs in AI and autonomous vehicles on a scale that no other country can match 
  • Innovation and application of renewable technology (think Next-Gen nuclear plants) 
  • Growth in Chinese domestic tourism, plus the overall hospitality and travel industry  
  • China Govies and credit 
  • Chinese tech plays (long undervalued and underperforming against US tech) 
  • Hong Kong being a contrarian play (don’t want Chinese companies to list in the US? Fine, no problem, they can list at home be it Hong Kong or Shanghai)  
  • China upping their game on investor protection, governance and rule of law to attract foreign capital  

There will be a huge opportunity cost for the countries that choose to ignore dealing with 1.4 billion consumers and an economy that will become the largest in the world in most people’s lifetime. This opportunity cost will be an opportunity boon to others – such as Germany and the eurozone as a whole – who will capitalise by pivoting further towards China. 

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.